CYH Community Health Systems, Inc. Common Stock

NYSE · Health Care · Auf SEC EDGAR ansehen ↗
$3,01
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 23, 2026

Über Community Health Systems, Inc. Common Stock Unternehmensübersicht von Wikipedia

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

Mehr lesen

Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.

On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.

Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.

History

Founding and early years (1985–2014)

E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.

The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.

In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.

In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.

In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.

In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.

In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.

On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.

It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.

Recent developments (2015–present)

On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.

In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.

After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.

On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.

In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.

In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.

In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.

On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.

On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.

On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.

In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.

On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.

On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.

In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.

In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.

From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.

Predatory liens practices

Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

CYH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$3.00
Marktkapitalisierung
$417M
P/E (TTM)
0.8
EPS (TTM)
$3.77
Umsatz (TTM)
$12.48B
Dividendenrendite
ROE
-30.8%
Verschuldungsgrad
-7.4
52W-Spanne
$2 – $4

CYH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $12.48B
10-point trend, -32.3%
2016-12-31 2025-12-31
EPS $3.77
10-point trend, +124.3%
2016-12-31 2025-12-31
Freier Cashflow $208M
10-point trend, -47.1%
2016-12-31 2025-12-31
Margen 4.1%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
CYH
Peer-Median
P/E (TTM)
5-point trend, -89.1%
0.8
13.1
P/S (TTM) (K/V (TTM))
5-point trend, -75.7%
0.0
1.1
P/B (K/B)
5-point trend, +75.8%
-0.3
1.8
EV / EBITDA
5-point trend, -25.6%
7.1
Price / FCF (Kurs / FCF)
5-point trend, +170.9%
2.0

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
CYH
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, +5.1%
11.9%
Net Profit Margin (Nettogewinnmarge)
5-point trend, +119.4%
4.1%
2.9%
ROA
5-point trend, +153.7%
3.7%
2.7%
ROE
5-point trend, -100.5%
-30.8%
1.3%
ROIC
5-point trend, +60.5%
15.5%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
CYH
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
5-point trend, +15.6%
-7.4
Current Ratio (Liquiditätsgrad)
5-point trend, -0.5%
1.5
1.5
Quick Ratio
5-point trend, -2.6%
1.1

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
CYH
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +0.9%
-1.2%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +0.9%
0.74%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +0.9%
1.1%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
CYH
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +114.2%
$3.77

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
CYH
Peer-Median

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite
Ausschüttungsquote
5J Div CAGR
Ex-DatumBetrag
13. Dezember 2012$0,2066

CYH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

HALTEN 16 Analysten
  • Starker Kauf 1 6,2%
  • Kauf 1 6,2%
  • Halten 6 37,5%
  • Verkauf 7 43,8%
  • Starker Verkauf 1 6,2%

12-Monats-Kursziel

7 Analysten · 2026-08-13
Median-Ziel $3.25 +8,2%
Mittelwert-Ziel $3.18 +5,8%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.20%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-0.19 $-0.06 -0.13%
31. März 2026 $-0.48 $-0.10 -0.38%
31. Dezember 2025 $-0.01 $-0.10 0.10%
30. September 2025 $1.27 $-0.25 1.5%
30. Juni 2025 $-0.05 $-0.11 0.06%
31. März 2025 $-0.03 $-0.08 0.05%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CYH $433M 0.8 -1.2% 4.1% -30.8%
SNDA $612M -7.7 25.2% -18.6% -197.2%
ARDT $1.26B 9.2 6.0% 2.1% 11.2%
NUTX $1.17B 15.7 82.4% 8.1% 30.6% 50.8%
USPH 55.0 16.3% 5.1% 8.2% 19.2%
JYNT $123M 45.9 5.2% 5.3% 16.3%
HCA $104.86B 16.5 7.1% 9.0% -159.1%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 13
Jährliche Gewinn- und Verlustrechnung-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue 10-point trend, -32.3% $12.48B $12.63B $12.49B $12.21B $12.37B $11.79B $13.21B $14.15B $15.35B $18.44B
Cost of Revenue 10-point trend, -38.1% $1.86B $1.95B $1.99B $1.98B $2.04B $1.96B $2.15B $2.35B $2.67B $3.01B
Operating Expenses 10-point trend, -43.0% $11.00B $12.09B $11.53B $11.39B $10.97B $10.66B $12.56B $13.95B $17.23B $19.30B
Operating Income 10-point trend, +273.0% $1.49B $542M $957M $821M $1.40B $1.13B $650M $208M $-1.88B $-860M
Interest Income 10-point trend, -85.7% $2M $3M $2M $2M $3M $3M $3M $7M $11M $14M
Pretax Income 10-point trend, +142.2% $724M $-283M $207M $349M $499M $422M $-430M $-715M $-2.83B $-1.72B
Income Tax 10-point trend, +146.2% $48M $79M $191M $170M $131M $-185M $160M $-11M $-449M $-104M
Net Income 10-point trend, +129.6% $509M $-516M $-133M $46M $230M $511M $-675M $-788M $-2.46B $-1.72B
EPS (Basic) 10-point trend, +124.5% $3.81 $-3.90 $-1.02 $0.35 $1.82 $4.43 $-5.93 $-6.99 $-22.00 $-15.54
EPS (Diluted) 10-point trend, +124.3% $3.77 $-3.90 $-1.02 $0.35 $1.76 $4.39 $-5.93 $-6.99 $-22.00 $-15.54
Shares (Basic) 10-point trend, +20.6% 133,564,227 132,101,768 130,445,677 128,808,387 126,754,852 115,491,022 113,739,046 112,728,274 111,769,821 110,730,971
Shares (Diluted) 10-point trend, +21.9% 135,012,240 132,101,768 130,445,677 130,060,319 130,597,410 116,544,561 113,739,046 112,728,274 111,769,821 110,730,971
EBITDA 10-point trend, +520.0% $1.49B $542M $957M $821M $1.40B $1.13B $1.26B $908M $-1.02B $240M
Bilanz 26
Jährliche Bilanz-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +9.2% $260M $37M $38M $118M $507M $1.68B $216M $196M $563M $238M
Receivables 10-point trend, -34.6% $2.08B $2.29B $2.23B $2.04B $2.06B $1.93B $2.26B $2.35B $2.38B $3.18B
Other Current Assets 10-point trend, -32.9% $381M $358M $275M $235M $269M $338M $358M $400M $462M $568M
Current Assets 10-point trend, -30.7% $3.23B $3.30B $3.21B $3.08B $3.48B $4.51B $3.43B $3.55B $4.07B $4.67B
PP&E (Net) 10-point trend, -44.7% $4.50B $4.78B $5.21B $5.37B $5.55B $5.32B $5.61B $6.14B $7.05B $8.15B
PP&E (Gross) 10-point trend, -28.3% $8.91B $9.16B $9.51B $9.64B $9.76B $9.35B $9.65B $10.30B $11.50B $12.42B
Accum. Depreciation 10-point trend, +3.2% $4.41B $4.38B $4.30B $4.27B $4.20B $4.03B $4.04B $4.16B $4.45B $4.27B
Goodwill 10-point trend, -49.1% $3.32B $3.79B $3.96B $4.17B $4.22B $4.22B $4.33B $4.56B $4.72B $6.52B
Intangibles 6-point trend, -50.0% $7M $15M $20M $2M · · · · $10M $14M
Other Non-current Assets 10-point trend, -19.0% $2.10B $2.17B $2.05B $2.01B $1.91B $1.90B $2.21B $1.54B $1.54B $2.59B
Total Assets 10-point trend, -39.8% $13.20B $14.05B $14.46B $14.67B $15.22B $16.01B $15.61B $15.86B $17.45B $21.94B
Accounts Payable 10-point trend, -15.4% $842M $913M $912M $773M $830M $783M $811M $887M $967M $995M
Accrued Liabilities 4-point trend, -8.5% · · · · · · $1.13B $1.09B $1.13B $1.23B
Current Liabilities 10-point trend, -23.5% $2.21B $2.35B $2.14B $2.19B $2.36B $2.81B $2.28B $2.39B $2.36B $2.89B
Capital Leases 10-point trend, +77.8% $537M $535M $563M $605M $535M $524M $487M $84M $287M $302M
Deferred Tax 10-point trend, -93.9% $25M $231M $369M $354M $192M $29M $200M $26M $19M $411M
Other Non-current Liabilities 10-point trend, -43.4% $891M $828M $739M $644M $827M $1.60B $894M $1.01B $1.36B $1.57B
Total Liabilities 10-point trend, -28.6% $14.04B $15.37B $15.28B $15.40B $16.03B $17.06B $17.25B $16.82B $17.61B $19.66B
Long-term Debt 10-point trend, -31.8% $10.40B $11.45B $11.49B $11.63B $12.14B $12.22B $13.40B $13.60B $13.91B $15.24B
Total Debt 7-point trend, -22.5% $10.38B $11.43B $11.47B $11.61B $12.11B $12.09B $13.38B · · ·
Common Stock Flat — no change across 10 periods $1M $1M $1M $1M $1M $1M $1M $1M $1M $1M
Retained Earnings 10-point trend, -1094.3% $-3.57B $-4.08B $-3.56B $-3.43B $-3.48B $-3.71B $-4.22B $-3.54B $-2.76B $-299M
AOCI 10-point trend, +85.5% $-9M $-10M $-14M $-21M $-14M $-13M $-9M $-10M $-21M $-62M
Stockholders' Equity 10-point trend, -186.3% $-1.39B $-1.91B $-1.39B $-1.37B $-1.37B $-1.62B $-2.22B $-1.53B $-767M $1.61B
Liabilities + Equity 10-point trend, -39.8% $13.20B $14.05B $14.46B $14.67B $15.22B $16.01B $15.61B $15.86B $17.45B $21.94B
Shares Outstanding 10-point trend, +21.7% 138,626,917 138,919,641 136,774,911 134,703,717 132,146,282 129,612,117 117,822,631 116,248,376 114,651,004 113,876,580
Cashflow 13
Jährliche Cashflow-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
D&A 10-point trend, -61.3% $426M $486M $505M $534M $540M $558M $608M $700M $861M $1.10B
Stock-based Comp 10-point trend, -76.1% $11M $17M $22M $20M $25M $13M $10M $13M $24M $46M
Deferred Tax 10-point trend, -109.5% $-243M $-116M $35M $165M $171M $-187M $203M $-3M $-454M $-116M
Restructuring · · · · $3M · · · · ·
Other Non-cash 4-point trend, -86.9% · · · · · · $239M $352M $2.80B $1.83B
Operating Cash Flow 10-point trend, -52.2% $543M $480M $210M $300M $-131M $2.18B $385M $274M $773M $1.14B
CapEx 10-point trend, -55.0% $335M $360M $467M $415M $469M $440M $438M $527M $564M $744M
Investing Cash Flow 10-point trend, +34.4% $847M $-275M $-26M $-259M $-524M $177M $-2M $-245M $1.07B $630M
Net Debt Issued 10-point trend, +3.0% $-6.52B $-5.06B $-4.32B $-2.36B $-4.43B $-5.49B $-3.56B $-2.03B $-5.39B $-6.71B
Financing Cash Flow 10-point trend, +31.9% $-1.17B $-206M $-264M $-430M $-514M $-895M $-363M $-396M $-1.52B $-1.71B
Net Change in Cash 10-point trend, +313.0% $223M $-1M $-80M $-389M $-1.17B $1.46B $20M $-367M $325M $54M
Taxes Paid 10-point trend, +1456.2% $249M $171M $91M $-6M $-4M $-2M $3M $19M $-4M $16M
Free Cash Flow 10-point trend, -47.1% $208M $120M $-257M $-115M $-600M $1.74B $-53M $-253M $209M $393M
Rentabilität 7
Jährliche Rentabilität-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Operating Margin 8-point trend, +710.9% 11.9% 4.3% 7.7% 6.7% 11.3% 9.6% 4.9% 1.5% · ·
Net Margin 8-point trend, +173.2% 4.1% -4.1% -1.1% 0.38% 1.9% 4.3% -5.1% -5.6% · ·
Pretax Margin 8-point trend, +214.9% 5.8% -2.2% 1.7% 2.9% 4.0% 3.6% -3.3% -5.1% · ·
EBITDA Margin 8-point trend, +86.0% 11.9% 4.3% 7.7% 6.7% 11.3% 9.6% 9.5% 6.4% · ·
ROA 10-point trend, +152.6% 3.7% -3.6% -0.91% 0.31% 1.5% 3.2% -4.3% -4.7% -12.5% -7.1%
ROE 10-point trend, +49.6% -30.8% 31.2% 9.6% -3.4% -15.3% -26.6% 36.0% 68.5% -580.0% -61.1%
ROIC 10-point trend, +130.9% 15.5% 7.3% 0.73% 4.1% 9.6% 15.5% 8.0% -13.3% 206.0% -50.0%
Liquidität & Solvenz 4
Jährliche Liquidität & Solvenz-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -9.4% 1.5 1.4 1.5 1.4 1.5 1.6 1.5 1.5 1.7 1.6
Quick Ratio 10-point trend, -10.5% 1.1 1.0 1.1 1.0 1.1 1.3 1.1 1.1 1.3 1.2
Debt / Equity 7-point trend, -23.4% -7.4 -6.0 -8.2 -8.5 -8.8 -7.4 -6.0 · · ·
LT Debt / Equity 7-point trend, -23.4% -7.4 -6.0 -8.2 -8.5 -8.8 -7.4 -6.0 · · ·
Effizienz 2
Jährliche Effizienz-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +7.8% 0.9 0.9 0.9 0.8 0.8 0.7 0.8 0.8 · ·
Receivables Turnover 8-point trend, -4.3% 5.7 5.6 5.8 6.0 6.2 5.6 5.7 6.0 · ·
Pro Aktie 5
Jährliche Pro Aktie-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -170.9% $-10.06 $-13.78 $-10.18 $-10.15 $-10.38 $-12.54 $-18.82 $-13.20 $-6.69 $14.18
Revenue / Share 8-point trend, -26.4% $92.47 $95.64 $95.75 $93.89 $94.70 $101.15 $116.14 $125.57 · ·
Cash Flow / Share 10-point trend, -60.8% $4.02 $3.63 $1.61 $2.31 $-1.00 $18.69 $3.38 $2.43 $6.92 $10.27
Cash / Share 10-point trend, -10.3% $1.88 $0.27 $0.28 $0.88 $3.84 $12.93 $1.83 $1.69 $4.91 $2.09
EPS (TTM) 10-point trend, +124.3% $3.77 $-3.90 $-1.02 $0.35 $1.76 $4.39 $-5.93 $-6.99 $-22.00 $-15.54
Wachstumsraten 9
Jährliche Wachstumsraten-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -124.0% -1.2% 1.1% 2.3% -1.3% 4.9% · · · · ·
Revenue CAGR 3Y 3-point trend, -61.9% 0.74% 0.71% 1.9% · · · · · · ·
Revenue CAGR 5Y 1.1% · · · · · · · · ·
EPS YoY 2-point trend, -33.7% · · · -80.1% -59.9% · · · · ·
EPS CAGR 3Y 120.8% · · · · · · · · ·
EPS CAGR 5Y -3.0% · · · · · · · · ·
Net Income YoY 2-point trend, -45.5% · · · -80.0% -55.0% · · · · ·
Net Income CAGR 3Y 122.8% · · · · · · · · ·
Net Income CAGR 5Y -0.08% · · · · · · · · ·
Bewertung (TTM) 13
Jährliche Bewertung (TTM)-Daten für CYH
Kennzahl Trend 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, -32.3% $12.48B $12.63B $12.49B $12.21B $12.37B $11.79B $13.21B $14.15B $15.35B $18.44B
Net Income TTM 10-point trend, +129.6% $509M $-516M $-133M $46M $230M $511M $-675M $-788M $-2.46B $-1.72B
Market Cap 10-point trend, -32.1% $433M $415M $428M $582M $1.76B $963M $342M $328M $488M $637M
Enterprise Value 7-point trend, -21.9% $10.55B $11.81B $11.86B $12.08B $13.36B $11.38B $13.51B · · ·
P/E 10-point trend, +330.1% 0.8 -0.8 -3.1 12.3 7.6 1.7 -0.5 -0.4 -0.2 -0.4
P/S 10-point trend, +0.3% 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0
P/B 10-point trend, -178.7% -0.3 -0.2 -0.3 -0.4 -1.3 -0.6 -0.2 -0.2 -0.6 0.4
P / Cash Flow 10-point trend, +42.3% 0.8 0.9 2.0 1.9 -13.4 0.4 0.9 1.2 0.6 0.6
P / FCF 10-point trend, +28.4% 2.1 3.5 -1.7 -5.1 -2.9 0.6 -6.4 -1.3 2.3 1.6
EV / EBITDA 7-point trend, -34.0% 7.1 21.8 12.4 14.7 9.5 10.1 10.7 · · ·
EV / FCF 7-point trend, +119.9% 50.7 98.4 -46.1 -105.0 -22.3 6.5 -254.9 · · ·
EV / Revenue 7-point trend, -17.4% 0.8 0.9 0.9 1.0 1.1 1.0 1.0 · · ·
Earnings Yield 10-point trend, +143.5% 120.8% -130.4% -32.6% 8.1% 13.2% 59.1% -204.5% -247.9% -516.4% -278.0%

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $12.48B$12.63B$12.49B$12.21B$12.37B
Betriebsgewinnmarge % 11.9%4.3%7.7%6.7%11.3%
Nettoergebnis $509M$-516M$-133M$46M$230M
Verwässerte EPS $3.77$-3.90$-1.02$0.35$1.76
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fremdkapital / Eigenkapital -7.4-6.0-8.2-8.5-8.8
Liquiditätsgrad 1.51.41.51.41.5
Quick Ratio 1.11.01.11.01.1
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $208M$120M$-257M$-115M$-600M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 201 Einreicher · $341.1M gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
37 (+19 vs. Vorquartal) 24 (+4 vs. Vorquartal) 65 (+4 vs. Vorquartal) 49 (-12 vs. Vorquartal) +15.7M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
CastleKnight Management LP $44.704.517 13.384.586 13,10% Aktien
Apollo Management Holdings, L.P. $39.610.817 11.859.526 11,61% Aktien
Eversept Partners, LP $26.267.680 7.864.575 7,70% Aktien
VANGUARD GROUP INC $25.789.362 8.265.821 7,56% Aktien
NOMURA HOLDINGS INC $22.388.384 6.703.109 6,56% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $17.668.370 5.289.931 5,18% Aktien
WHITEBOX ADVISORS LLC $12.467.362 3.732.743 3,65% Aktien
STATE STREET CORP $10.226.622 3.061.863 3,00% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $10.082.117 3.018.598 2,96% Aktien
Saba Capital Management, L.P. $9.626.444 2.882.169 2,82% Aktien
GEODE CAPITAL MANAGEMENT, LLC $9.084.165 2.719.143 2,66% Aktien
Owl Creek Asset Management, L.P. $8.452.277 2.530.622 2,48% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $8.176.380 2.448.018 2,40% Aktien
DIMENSIONAL FUND ADVISORS LP $7.510.531 2.248.662 2,20% Aktien
TWO SIGMA INVESTMENTS, LP $7.365.822 2.205.336 2,16% Aktien
Diameter Capital Partners LP $6.138.793 1.837.962 1,80% Aktien
TWO SIGMA ADVISERS, LP $5.816.476 1.864.255 1,70% Aktien
CARRONADE CAPITAL MANAGEMENT, LP $5.230.000 1.565.847 1,53% Aktien
Allianz Asset Management GmbH $5.167.919 1.547.281 1,51% Aktien
D. E. Shaw & Co., Inc. $4.779.143 1.430.881 1,40% Aktien
Silver Rock Financial LP $3.674.000 1.100.000 1,08% Aktien
CITADEL ADVISORS LLC $3.177.085 951.223 0,93% Aktien
Assenagon Asset Management S.A. $2.788.275 834.813 0,82% Aktien
VANGUARD FIDUCIARY TRUST CO $2.642.231 791.087 0,77% Aktien
BANK OF AMERICA CORP /DE/ $2.566.736 768.484 0,75% Aktien
Jefferies Financial Group Inc. $2.481.286 742.900 0,73% Aktien
Alta Fundamental Advisers LLC $2.161.411 647.129 0,63% Aktien
GOLDMAN SACHS GROUP INC $2.016.194 603.651 0,59% Aktien
MILLENNIUM MANAGEMENT LLC $1.701.580 509.455 0,50% Aktien
ExodusPoint Capital Management, LP $1.664.603 498.384 0,49% Aktien
READYSTATE ASSET MANAGEMENT LP $1.657.729 496.326 0,49% Aktien
WOLVERINE ASSET MANAGEMENT LLC $1.339.674 401.100 0,39% Kaufoption
Helix Partners Management LP $1.336.000 400.000 0,39% Aktien
Bank of New York Mellon Corp $1.325.679 396.910 0,39% Aktien
Susquehanna Portfolio Strategies, LLC $1.280.940 383.515 0,38% Aktien
Voleon Capital Management LP $1.247.032 373.363 0,37% Aktien
TUDOR INVESTMENT CORP ET AL $999.388 299.218 0,29% Aktien
Pathstone Holdings, LLC $895.621 268.150 0,26% Aktien
Prescott Group Capital Management, L.L.C. $863.076 258.406 0,25% Aktien
MILLENNIUM MANAGEMENT LLC $835.000 250.000 0,24% Verkaufsoption
FEDERATED HERMES, INC. $812.599 243.293 0,24% Aktien
LPL Financial LLC $737.239 220.730 0,22% Aktien
IEQ CAPITAL, LLC $657.963 196.995 0,19% Aktien
RHUMBLINE ADVISERS $543.412 162.701 0,16% Aktien
Nuveen, LLC $535.683 160.384 0,16% Aktien
BOOTHBAY FUND MANAGEMENT, LLC $506.701 151.707 0,15% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $501.668 150.200 0,15% Kaufoption
Caption Management, LLC $501.000 150.000 0,15% Kaufoption
Nuveen Asset Management, LLC $479.548 160.384 0,14% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $442.056 132.352 0,13% Aktien
DEUTSCHE BANK AG\ $423.131 126.686 0,12% Aktien
State of Wyoming $386.675 115.771 0,11% Aktien
CAHABA WEALTH MANAGEMENT, INC. $367.400 110.000 0,11% Aktien
STRS OHIO $334.000 100.000 0,10% Aktien
EQUITABLE TRUST CO $334.000 100.000 0,10% Aktien
Turtle Creek Wealth Advisors, LLC $334.000 100.000 0,10% Aktien
Parkwoods Wealth Partners, LLC $330.319 98.898 0,10% Aktien
BNP PARIBAS FINANCIAL MARKETS $322.096 96.436 0,09% Aktien
CITIGROUP INC $321.361 96.216 0,09% Aktien
ALLIANCEBERNSTEIN L.P. $311.640 106.000 0,09% Aktien
Lombard Odier Asset Management (USA) Corp $297.260 89.000 0,09% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $287.908 86.200 0,08% Verkaufsoption
NorthCrest Asset Manangement, LLC $283.320 76.573 0,08% Aktien
MetLife Investment Management, LLC $278.232 83.303 0,08% Aktien
CITADEL ADVISORS LLC $242.818 72.700 0,07% Verkaufsoption
LAZARD ASSET MANAGEMENT LLC $240.887 72.122 0,07% Aktien
Cetera Investment Advisers $223.339 66.868 0,07% Aktien
Mariner, LLC $222.538 66.627 0,07% Aktien
Cerity Partners LLC $211.102 63.204 0,06% Aktien
Apollon Wealth Management, LLC $203.453 60.914 0,06% Aktien
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $199.755 59.807 0,06% Aktien
JANE STREET GROUP, LLC $179.692 53.800 0,05% Kaufoption
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $176.339 128.756 0,05% Aktien
Invesco Ltd. $171.559 51.365 0,05% Aktien
CITADEL ADVISORS LLC $153.640 46.000 0,05% Kaufoption
MERCER GLOBAL ADVISORS INC /ADV $150.911 45.183 0,04% Aktien
Schonfeld Strategic Advisors LLC $147.660 44.210 0,04% Aktien
Vanguard Global Advisers, LLC $144.134 43.154 0,04% Aktien
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $136.659 40.916 0,04% Aktien
Red Door Wealth Management, LLC $130.260 39.000 0,04% Aktien
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $128.810 38.566 0,04% Aktien
BlackRock, Inc. $126.606 37.906 0,04% Aktien
XTX Topco Ltd $126.098 37.754 0,04% Aktien
GROUP ONE TRADING LLC $123.633 37.016 0,04% Aktien
Bison Wealth, LLC $121.992 33.150 0,04% Aktien
MANUFACTURERS LIFE INSURANCE COMPANY, THE $116.957 35.017 0,03% Aktien
Nebula Research & Development LLC $116.025 34.125 0,03% Aktien
RAYMOND JAMES FINANCIAL INC $113.724 34.049 0,03% Aktien
Police & Firemen's Retirement System of New Jersey $111.419 33.359 0,03% Aktien
Quantbot Technologies LP $110.450 33.069 0,03% Aktien
WOLVERINE TRADING, LLC $108.016 34.400 0,03% Kaufoption
INTECH INVESTMENT MANAGEMENT LLC $107.535 32.196 0,03% Aktien
Advisory Services Network, LLC $105.845 31.690 0,03% Aktien
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $105.537 31.598 0,03% Aktien
Independent Advisor Alliance $99.766 29.870 0,03% Aktien
Callan Family Office, LLC $96.195 28.801 0,03% Aktien
CAPTRUST FINANCIAL ADVISORS $91.736 27.466 0,03% Aktien
Brevan Howard Capital Management LP $91.125 27.283 0,03% Aktien
Atom Investors LP $90.527 27.104 0,03% Aktien
Lakeview Capital Partners, LLC $89.580 29.960 0,03% Aktien

Unternehmensinsider 57 Insider · 29 Führungskräfte · 23 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Kevin J Hammons CEO 1. März 2026 A 895.545 0 0 $0
Tim Hingtgen CEO 1. März 2025 A 1.388.781 0 0 $0
Jason K Johnson EVP & CFO 1. März 2026 A 268.439 0 0 $0
Thomas J Aaron EVP and CFO 7. Dezember 2019 F 241.515 0 0 $0
Larry W Cash President and CFO 1. März 2017 A 568.152 0 0 $0
Miguel S Benet President and CMO 1. März 2025 D 47.635 0 0 $0
Austen D Mason Regional President 1. März 2025 A 142.500 0 0 $0
Mark B Medley Regional President 1. März 2025 A 128.637 0 0 $0
Chad A Campbell Regional President 1. März 2025 A 136.815 0 0 $0
Charles J Cova Regional President 1. März 2024 A 58.701 0 0 $0
Lynn T Simon President and CMO 1. März 2024 A 482.657 0 0 $0
Beryl Ramsey Division President 1. März 2019 A 62.969 0 0 $0
Patton Paul Smith Division President 1. März 2019 F 119.017 0 0 $0
Iii John W Mcclellan Division President 1. März 2017 A 41.242 0 0 $0
Robert O Horrar Division President 1. März 2017 A 68.649 0 0 $0
Martin Bonick Division President 1. März 2017 A 100.458 0 0 $0
Michael T Portacci Division President 1. März 2017 A 110.156 0 0 $0
Thomas Daniel Miller Division President 1. März 2016 A 112.107 0 0 $0
David Lewis Miller President and COO 1. März 2016 A 440.840 0 0 $0
William S Hussey Division President 28. Oktober 2015 M 121.568 0 0 $0
Martin Dewayne Smith Division President 3. Juni 2015 M 94.111 0 0 $0
Gary D Newsome Division President - Group Ops 25. August 2008 M 118.286 0 0 $0
David V. Rice EVP-Clinical Operations & CMO 1. Juni 2026 A 30.000 0 0 $0
Phillip A. Posey SVP & CAO 1. März 2026 A 51.736 0 0 $0
Justin D Pitt Pres,Chief Legal&Admin Officer 1. März 2026 A 287.750 0 0 $0
Kevin A Stockton EVP, Operations & Development 1. März 2026 A 208.290 0 0 $0
Rachel A Seifert Executive VP and Secretary 1. März 2017 F 243.065 0 0 $0
Mark T Buford SVP/Chief Accounting Officer 25. Februar 2012 F 78.379 0 0 $0
Martin G Schweinhart Senior Vice President 1. März 2006 A 40.354 0 0 $0
Ranga K Krishnan Direktor 30. Juni 2026 M 170.023 0 0 $0
Fawn D Lopez Direktor 1. März 2026 A 0 0 $0
Ronald L Burgess JR Direktor 1. März 2026 A 0 0 $0
Susan W Brooks Direktor 1. März 2026 A 108.695 0 0 $0
Hubert James Williams Direktor 1. März 2026 A 211.863 0 0 $0
Joseph Arthur Hastings Direktor 1. März 2026 A 0 0 0 $0
Elizabeth T Hirsch Direktor 1. März 2026 A 162.059 0 0 $0
James S. Ely III Direktor 1. März 2026 A 412.876 0 0 $0
William Norris Jennings Direktor 1. März 2026 A 78.468 0 0 $0
John A Fry Direktor 1. März 2026 A 268.966 0 0 $0
John A Clerico Direktor 1. März 2026 A 368.763 0 0 $0
Michael Dinkins Direktor 1. März 2026 A 225.882 0 0 $0
Wayne T Smith Direktor 1. März 2026 A 5.217.579 0 0 $0
Julia B North Direktor 1. März 2021 A 162.056 0 0 $0
Mitchell H Watson JR Direktor 16. Mai 2017 M 22.594 0 0 $0
Harvey Klein MD Direktor 15. März 2010 M 10.383 0 0 $0
Dale F Frey Direktor 31. März 2008 A 20.000 0 0 $0
Thomas H Lister Direktor 21. September 2004 S 0 0 0 $0
Thodore Forstmann Direktor 21. September 2004 S 0 0 0 $0
Sandra Horbach Direktor 21. September 2004 S 0 0 0 $0
Robert J Dole Direktor 6. Mai 2004 S 0 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 1 Beteiligung

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 Einreichungen 11. März 2021 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 36 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
BSJR · Invesco Exchange-Traded Self-Indexe… 2,68% 21.287.000 8. August 2026 Täglich
EBIT · Harbor ETF Trust 0,48% 19.323 NS 30. April 2026 N-PORT
VGHY · VANGUARD FIXED INCOME SECURITIES FU… 0,35% 1.058.000 PA 8. August 2026 Täglich
DFVE · DoubleLine ETF Trust 0,20% 18.550 NS 31. März 2026 N-PORT
IWC · iShares Trust 0,09% 441.586 SH 8. August 2026 Täglich
IHF · iShares Trust 0,06% 232.511 SH 8. August 2026 Täglich
GSSC · Goldman Sachs ETF Trust 0,04% 132.595 NS 31. Mai 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0,03% 113.109 SH 8. August 2026 Täglich
NEAR · iShares U.S. ETF Trust 0,03% 1.304.000 SH 8. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust 0,03% 253.747 SH 8. August 2026 Täglich
IWN · iShares Trust 0,02% 1.218.442 SH 8. August 2026 Täglich
IWM · iShares Trust 0,01% 3.418.265 SH 8. August 2026 Täglich
FNDX · SCHWAB STRATEGIC TRUST 0,01% 1.126.552 NS 31. Mai 2026 N-PORT
RSSL · Global X Funds 0,01% 56.434 NS 30. April 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,01% 53.684 NS 31. Mai 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 746.733 SH 8. August 2026 Täglich
VHT · VANGUARD WORLD FUND 0,01% 349.881 SH 8. August 2026 Täglich
DFAS · Dimensional ETF Trust 0,01% 466.961 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,01% 6.034 NS 31. Mai 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,01% 546.576 NS 31. Mai 2026 N-PORT
UWM · ProShares Trust 0,01% 4.719 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,00% 4.772 NS 31. Mai 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,00% 5.006 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,00% 120 NS 31. Mai 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 202.789 NS 30. April 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 33.838 NS 30. April 2026 N-PORT
ITOT · iShares Trust 0,00% 203.866 SH 8. August 2026 Täglich
IWV · iShares Trust 0,00% 41.727 SH 8. August 2026 Täglich
DCOR · Dimensional ETF Trust 0,00% 6.184 NS 30. April 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 31.135 NS 30. April 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 70.316 NS 31. Mai 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,00% 1.347.195 SH 8. August 2026 Täglich
VTI · VANGUARD INDEX FUNDS 0,00% 3.813.888 SH 8. August 2026 Täglich
VPLS · VANGUARD MALVERN FUNDS 0,00% 20.000 PA 8. August 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 9.817 SH 8. August 2026 Täglich
DFSU · Dimensional ETF Trust 0,00% 24 NS 30. April 2026 N-PORT